Press Releases
Partner Therapeutics Wins $35M DoD Contract for Leukine in COVID-19
Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, anounced a $35 million milestone-based Other Transaction Agreement (OTA) with the U.S. Department of Defense (DOD)...
News
SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity
Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in...
News
Thermo Fisher Expands Model Options for SampleManager LIMS
Thermo Fisher Scientific has expanded deployment model options for SampleManager LIMS software, offering laboratories support of the software deployment in the Amazon Web Services...
Press Releases
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Articles
Cartridge filling: Understanding the complexities
By 2050, it is projected that the proportion of people aged 65 and older will be more than double that of children aged 5....
News
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
Pfizer Inc and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses...
Press Releases
Novartis Cosentyx receives EU approval for first-line systemic treatment in pediatric psoriasis
Novartis, a leader in immuno-dermatology and rheumatology, announced the EC has granted the approval for Cosentyx® (secukinumab) for the treatment of moderate-to-severe plaque psoriasis...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read